一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Cell Communication and Signaling >>article
Cell Communication and Signaling

Cell Communication and Signaling

IF: 8.2
Download PDF

Paracrine secretion of IL8 by breast cancer stem cells promotes therapeutic resistance and metastasis of the bulk tumor cells

Published:13 March 2023 DOI: 10.1186/s12964-023-01068-6 PMID: 36915147
Mingming Wu, Xiao Zhang, Weijie Zhang, Linlin Yan, Xiangtian Liu, Min Zhang, Yueyin Pan, Peter E Lobie, Xinghua Han, Tao Zhu

Abstract

Background: Breast tumors consist of heterogeneous cellular subpopulations that differ in molecular properties and functional attributes. Cancer stem cells (CSCs) play pivotal roles in cancer therapeutic failure and metastasis. However, it remains indeterminate how CSCs determine the progression of the bulk cancer cell population.

Methods: Co-culture systems in vitro and co-implantation systems in vivo were designed to characterize the interactions between breast cancer stem cells (BCSCs) and bulk cancer cells. RNA sequencing was performed to study the functional and mechanistic implications of the BCSC secretome on bulk cancer cells. A cytokine antibody array was employed to screen the differentially secreted cytokines in the BCSC secretome. Tail vein injection metastatic models and orthotopic xenograft models were applied to study the therapeutic potential of targeting IL8.

Results: We identified that the BCSC secretome potentiated estrogen receptor (ER) activity in the bulk cancer cell population. The BCSC secretome rendered the bulk cancer cell population resistant to anti-estrogen and CDK4/6 inhibitor therapy; as well as increased the metastatic burden attributable to bulk cancer cells. Screening of the BCSC secretome identified IL8 as a pivotal factor that potentiated ERα activity, endowed tamoxifen resistance and enhanced metastatic burden by regulation of bulk cancer cell behavior. Pharmacological inhibition of IL8 increased the efficacy of fulvestrant and/or palbociclib by reversing tamoxifen resistance and abrogated metastatic burden.

Conclusion: Taken together, this study delineates the mechanism by which BCSCs determine the therapeutic response and metastasis of bulk cancer cells; and thereby suggests potential therapeutic strategies to ameliorate breast cancer outcomes. Video Abstract.

Substances (9)

Materials Related products
Procduct Name CAS Molecular Formula Supplier Price
CHIR-99021 252917-06-9 C22H18Cl2N8 343 suppliers $28.00-$4401.00
CHIR-99021 252917-06-9 C22H18Cl2N8 343 suppliers $28.00-$4401.00
CHIR-99021 252917-06-9 C22H18Cl2N8 343 suppliers $28.00-$4401.00
CHIR-99021 252917-06-9 C22H18Cl2N8 343 suppliers $28.00-$4401.00
xav-939 284028-89-3 C14H11F3N2OS 241 suppliers $7.00-$3173.00
xav-939 284028-89-3 C14H11F3N2OS 241 suppliers $7.00-$3173.00
xav-939 284028-89-3 C14H11F3N2OS 241 suppliers $7.00-$3173.00
xav-939 284028-89-3 C14H11F3N2OS 241 suppliers $7.00-$3173.00

Similar articles

景洪市| 灵台县| 永登县| 绥滨县| 荃湾区| 渭南市| 慈溪市| 金山区| 鹤峰县| 仙居县| 民县| 济源市| 宜川县| 湖口县| 辽源市| 洛宁县| 盈江县| 油尖旺区| 德庆县| 柳林县| 全椒县| 开化县| 墨玉县| 尤溪县| 股票| 光山县| 木兰县| 读书| 景宁| 青河县| 饶平县| 咸阳市| 绵阳市| 鸡东县| 特克斯县| 岐山县| 富阳市| 铁岭市| 布尔津县| 延津县| 昌江|